SUPARTZ FX
Device
SEIKAGAKU CORPORATION
Total Payments
$11,985
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $11,985 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11,985 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy of SUPARTZ FX for subchondral bone protection in murine overuse osteoarthritis | SEIKAGAKU CORPORATION | $11,985 | 0 |
Top Doctors Receiving Payments for SUPARTZ FX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $11,985 | 1 |
Ad
Manufacturing Companies
- SEIKAGAKU CORPORATION $11,985
Product Information
- Type Device
- Total Payments $11,985
- Total Doctors 0
- Transactions 1
About SUPARTZ FX
SUPARTZ FX is a device associated with $11,985 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is SEIKAGAKU CORPORATION.
Payment data is available from 2018 to 2018. In 2018, $11,985 was paid across 1 transactions to 0 doctors.
The most common payment nature for SUPARTZ FX is "Unspecified" ($11,985, 100.0% of total).
SUPARTZ FX is associated with 1 research study, including "Efficacy of SUPARTZ FX for subchondral bone protection in murine overuse osteoarthritis" ($11,985).